COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges
Review Article
[키워드] “cytokine storm”
angiotensin-converting enzyme 2
article
assessment
CD209L
challenge
Coronavirus infection
COVID-19
COVID-19 disease
database
disease
Effect
eukaryotic translation
explain
General population
higher risk
IBD
immunopathology
Immunosuppressive medication
increased risk
Infection
infectious risk
Inflammatory bowel disease
inflammatory bowel diseases
Interaction
interferon signaling
knowledge
management
medication
MERS-CoV
molecular
Neural
novel coronavirus SARS-CoV-2
outbreak
outcome
outcomes
Pathogenesis
pathogenic coronavirus
pathway
Patient
Patient care
phosphorylated
Protective
public health
receptors
SARS-CoV-1
SARS-CoV-2
SARS-COV-2 infection
second
subunit
Support
susceptibility
therapeutic
threat
Treatment
treatment strategy
viral endocytosis
was used
yielding
[DOI] 10.1155/2020/1918035 PMC 바로가기 [Article Type] Review Article
[DOI] 10.1155/2020/1918035 PMC 바로가기 [Article Type] Review Article